Aeglea BioTherapeutics, Inc. 4
4 · Aeglea BioTherapeutics, Inc. · Filed May 19, 2016
Insider Transaction Report
Form 4
Lowe David George
DirectorCEO and President
Transactions
- Award
Employee Stock Option (right to buy)
2016-05-17+160,000→ 160,000 totalExercise: $7.28Exp: 2026-05-16→ Common Stock (160,000 underlying)
Footnotes (1)
- [F1]The stock option vests and becomes exercisable in 48 equal monthly installments beginning on June 17, 2016, until such time as the option is 100% vested, subject to the continuing employment of the Reporting Person on each vesting date.